Winners ECNP Excellence Awards 2020

P.032 
Cannabidiol-mediated effects on behavioural and gene expression changes induced by a new animal model of spontaneous cocaine withdrawal
Ani Gasparyan, Spain

P.047
White matter microstructure and attention-deficit/hyperactivity symptoms: cross-sectional and longitudinal effects
Christienne Damatac, The Netherlands

P.124
Linking functional and structural brain organisation in autism spectrum disorder
Natalie Forde, The Netherlands

P.160
Associations between selective serotonin reuptake inhibitors and violent crime in adolescents, young, and older adults - a Swedish register-based study
Tyra Lagerberg, Sweden

P.179
Polygenic risk scores for multiple psychiatric, inflammatory and cardio-metabolic traits highlight possible genetic overlap with suicide attempt
Giuseppe Fanelli, Italy

P.204
Behavioural and neural correlates of response inhibition in disruptive behaviour disorders
Gulhan Saracaydin, The Netherlands

P.223
Link between Serotonin 4 receptor brain binding and cognitive disturbances in major depressive disorder: a NeuroPharm study
Vibeke Høyrup Dam, Denmark

P.233
A psychobiotic diet decreases stress and depressive mood in healthy volunteers
Kirsten Berding,Ireland

P.238
Lithium treatment modulates the expression of inflammation involved genes in major depressive disorder
Kosma Sakrajda, Poland

P.253
Immunoassay quantification and neuroimaging data for differentiating bipolar and unipolar depression: support vector machine on kernels and elastic net approaches
Benedetta Vai, Italy

P.284
Neuroimaging evidence for increased neurite density in patients with bipolar disorder taking lithium: a replication study.
Samuel Sarrazin, France

P.298
Emotional cognition heterogeneity in patients with mood disorders and clinical implication
Cristina Varo, Spain

P.392
Cerebellar influence on the thalamo-prefrontal firing patterns during fear extinction
Ioana Antoaneta Georgescu, Romania

P.404
Cognitions and their associated neuronal substrates as mediating mechanism between dark personality and antisocial behaviour
Luna Rabl, Austria

P.426
Circadian variation of migraine attack onset influences brain activity during emotion processing - an fMRI study
Daniel Baksa, Hungary

P.443
Altered functional connectivity during combined sequential motor learning and one-week escitalopram administration
Eoin Molloy, Germany

P.452
Lithium in the prevention of relapse following successful electroconvulsive therapy for major depression: a systematic review and meta-analysis
Simon Lambrichts, Belgium

P.499
Ketamine’s influence on global resting-state functional connectivity and individual variation in neuro-behavioural relationships
Flora Moujaes, Switzerland

P.504
Targeting nitric oxide synthase 1 adaptor protein interactions as a possible treatment for schizophrenia: an initial proof-of-concept study in mice
Dilhan Esen-Sehir, Germany

P.507
Machine learning classification of first-episode psychosis using cortical thickness: a large multicenter magnetic resonance imaging study
Alessandro Pigoni, Italy

P.523
Neuromelanin MRI as biomarker for treatment resistance in first episode schizophrenia patients
Marieke Van Der Pluijm , The Netherlands

P.525
The relationship between synaptic density marker SV2A and glutamate: a multimodal positron emission tomography and magnetic resonance spectroscopy imaging study
Ellis Chika Onwordi, United Kingdom

P.540
Modelling the effects of maternal immune activation on early neurodevelopment using a human induced pluripotent stem cell derived system
Amalie Couch, United Kingdom

P.580
Metabolic predictors for mortality among clozapine–treated schizophrenia patients. An Israeli nationwide longitudinal study
Sharon Taub, Israel

P.598
Role of microRNAs in the mechanisms underlying stress vulnerability and resilience
Nadia Cattane, Italy

P.639
The individual’s personal experience of the living environment affects serotoninergic antidepressant treatment outcome
Naomi Ciano Albanese,Italy

P.660
The impact of the COVID-19 pandemic on mental health in a community-based population in Portugal: a case-control observational study
Gonçalo Santos, Portugal

P.661
Psychological impact of the COVID-19 outbreak and lockdown in Spanish sample with anxiety disorder: differences according to sex
Mercedes Valtueña García, Spain

P.711
The clinical and therapeutic challenges of comorbid obsessive-compulsive disorder and bipolar disorder in children and adolescents
Nádia Almeida Barradas, Portugal

P.721
Metabolomic profiles discriminating anxiety from depression
Hilde De Kluiver, The Netherlands

P.730
Characteristics of inflammation-related depression
Éimear M Foley, United Kingdom

P.772
Polysialic acid mimetics to target extrasynaptic NMDA receptors and rescue learning and memory in mouse models of neurodegenerative diseases
Shaobo Jia, Germany

P.777
Neurobiological correlates of antisocial behavior across adolescence: A multi-sample, multi-method study
Neeltje Blankenstein, The Netherlands

P.786
An increase in central nervous system signaling proteins as a criterion for the severity of schizophrenia
Elena Dmitrieva, Russia

P.804
A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain
Nakul Ravi Raval, Denmark

P.810
Real-world effectiveness of mood stabilizer use in persons with schizophrenia
Arto Puranen, Finland

P.831
Trajectories of suicidal ideation after a first-episode psychosis: a growth mixture modeling approach
Estela Salagre,Spain

P.861
Gender-specific involvement of Methyl-CpG binding protein 2 in vulnerability to stress: evidence from a healthy cohort
Livia Cosentino, Italy

P.865
Consequences of a single social defeat on accumbal dopamine measures: in vivo voltammetric study
Vsevolod Nemets, Russia

P.867
Effects of etifoxine on general but not stress related expression of the translocator protein 18kDa (TSPO) in healthy subjects
Lisa-Marie Bahr, Germany